Risk of carcinogenicity in patients with psoriasis treated with methotrexate or PUVA singly or in combination
- 30 September 1983
- journal article
- editorial
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 9 (3), 467-469
- https://doi.org/10.1016/s0190-9622(83)80215-1
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- SYNERGISTIC CARCINOGENIC POTENTIAL OF METHOTREXATE AND PUVA IN PSORIASISThe Lancet, 1983
- Aryl hydrocarbon hydroxylase and psoriasisBMJ, 1982
- Keratoses and nonmelanoma skin tumors in long-term photochemotherapy (PUVA)Journal of the American Academy of Dermatology, 1980
- Cell killing and mutagenesis by 8-methoxypsoralen in mammalian (rodent) cellsClinical and Experimental Dermatology, 1980
- Mutagenicity of 8-methoxypsoralen and long-wave ultraviolet irradiation in diploid human skin fibroblasts an imported risk estimate in photochemotherapyMutation Research, 1979
- 6-Thioguanine Resistant Peripheral Blood Lymphocytes in Humans Following Psoralen, Long-Wave Ultraviolet Light (PUVA) TherapyJournal of Investigative Dermatology, 1979
- Risk of Cutaneous Carcinoma in Patients Treated with Oral Methoxsalen Photochemotherapy for PsoriasisNew England Journal of Medicine, 1979
- Frameshift mutagenesis in bacteria by 8-methoxypsoralen (methoxalen) in the darkMutation Research, 1977
- Evidence that caffeine, 8-methoxypsoralen and steroidal diamines are frameshift mutagens for E. coli K-12Mutation Research, 1975
- Mutagenesis in Escherichia coli IV. Photosensitization to near ultraviolet light by 8-methoxypsoralenMutation Research, 1970